Reply to: Treatment of tics in patients with Tourette syndrome: Recommendations according to the European Society for the Study of Tourette Syndrome

Movement Disorders

Volumn 26, Issue 13, 2011, Pages 2448-

  Jankovic, Joseph ^a   Kurlan, Roger ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Overlook Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; GUANFACINE; HALOPERIDOL; PIMOZIDE; RISPERIDONE;

BEHAVIOR CHANGE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 81955161959     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23957     Document Type: Letter

References (6)

1. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011; 26: 1149-1156.
2. Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: randomized controlled trial. JAMA 2010; 303: 1929-1937.
3. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010; 81: 70-73.
4. Shin HW, Kim MJ, Kim JS, Lee MC, Chung SJ. Levosulpiride-induced movement disorders. Mov Disord 2009; 24: 2249-2253.
5. Peña MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord 2011; 26: 147-152.
6. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009; 8: 844-856.